Regeneron Pharmaceuticals Has Lost Its Way, But Can It Find It Again?
Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...
pharmaphorum3y
Regeneron's antibody cocktail hits target in COVID prevention study
The US pharma said results of the latest phase 3 trial showed that REGEN-COV (casirivimab+imdevimab) significantly reduced progression to symptomatic COVID-19 disease in uninfected individuals.
Mena FN5d
Regulatory Approvals Driving Market Growth In Expanding Indications: Key Trend In The Regen-Cov & Ronapreve Market 2025
The Business Research Company's Regen-cov And Ronapreve Global market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Updated 2025 Market Reports Released: Trends, Forecasts to ...
Seeking Alpha4d
REGN Regeneron Pharmaceuticals, Inc.
REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST ...
Brandeis University3y
The Art of Basic Science
It’s a dictum that has stood him well during his 30-year career as a top executive at Regeneron Pharmaceuticals, which received widespread publicity late last year after former President Donald Trump ...
GEN - Genetic Engineering and Biotechnology News3d
Macrophages Fight COVID-19-Induced Lung Damage with Peroxisomes
Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.